Forum on Voluntary Licensing and Access to Medicine (June 1-2, 2022)
A group of businesspeople, scholars, and activists met for two days at Harvard to discuss ways of increasing the availability of affordable medicines in developing countries. Details concerning the attendees and the topics discussed are available in the Conference Information Book. Summaries of the issues and questions addressed are available in the Conference Briefing Book.
Borderless COVID-19, Restricted Vaccines: Assessing the global pricing of vaccines and treatments (April 28, 2020)
As the novel coronavirus (COVID-19) sweeps the world in devastating fashion, scientists are scrambling to develop effective vaccines and treatments. But how should those medicines be priced globally?
Following Donald Trump’s “America First” policy with respect to vaccine and drug pricing would be tragic, argue Quentin Palfrey and John Stubbs. Instead, Palfrey and Stubbs propose a pharmaceutical pricing policy modeled on progressive taxation to distribute costs equitably worldwide. This discussion was moderated by Ashveena Gajeelee.
Drug Pricing Policies in the US and Globally: From Development to Delivery (October 24, 2018)
Innovation and Access: the Role of IP Licensing (Center for Strategic and International Studies) (September 26, 2017)
Conversation with Quentin Palfrey on Global Health, Innovation, and the Digital World (June 26, 2017)
Insights into Action: Practical Strategies to Expand Access to Medicine and Promote Innovation (June 13, 2016)
- Summary of the Conference Proceedings
- Presentation by Quentin Palfrey
- Presentation by Thomas Bollyky
- Presentation by Colleen Chien
- Presentation by Suerie Moon
- Presentation by Kevin Outterson
- Presentation by Hans Rietveld
- Presentation by Jami Taylor
- Presentation by Prashant Yadav